UPDATED May 15, 2024
Discover small cap Australian Pharmaceuticals & Biotech companies that are on the ASX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ME1 | AU$0.002 | -20.0% | -99.4% | AU$1.3m | n/a | PE-0.04x | n/a | n/a | ||
WFL | AU$0.003 | 0% | -87.0% | AU$1.5m | n/a | PE-0.2x | n/a | n/a | ||
RGS | AU$0.013 | 160.0% | 8.3% | AU$1.5m | n/a | PS4x | n/a | n/a | ||
HXL | AU$0.011 | -8.3% | 10.0% | AU$1.8m | n/a | PS9.5x | n/a | n/a | ||
BP8 | AU$0.001 | 0% | -75.0% | AU$2.0m | n/a | PE-0.8x | n/a | n/a | ||
VTL | AU$0.02 | 0% | n/a | AU$2.8m | n/a | PS112.4x | n/a | n/a | ||
NC6 | AU$0.021 | -4.5% | -54.3% | AU$3.6m | n/a | PS5.1x | n/a | n/a | ||
BOD | AU$0.024 | 0% | -65.2% | AU$4.3m | n/a | PS1.3x | n/a | n/a | ||
CMB | AU$0.007 | -12.5% | n/a | AU$4.3m | n/a | n/a | n/a | n/a | ||
EX1 | AU$0.011 | 0% | -81.7% | AU$4.8m | n/a | PS1.4x | n/a | n/a | ||
CGB | AU$0.021 | 0% | -72.0% | AU$5.4m | n/a | PS9.7x | n/a | n/a | ||
ZLD | AU$0.49 | -29.0% | -46.2% | AU$5.6m | n/a | PS19.9x | n/a | n/a | ||
IXC | AU$0.076 | -2.6% | -80.0% | AU$5.7m | n/a | PS469.1x | n/a | n/a | ||
NSB | AU$0.045 | -8.2% | -51.1% | AU$6.5m | n/a | PE8.5x | n/a | n/a | ||
ANR | AU$0.039 | 8.3% | 30.0% | AU$6.5m | n/a | PB5.2x | n/a | n/a | ||
EPN | AU$0.024 | 0% | 20.0% | AU$7.2m | n/a | PB0.8x | n/a | n/a | ||
ILA | AU$0.063 | 6.8% | -47.5% | AU$7.2m | n/a | PS7.5x | E0.8% | n/a | ||
AVE | AU$0.003 | -25.0% | -40.0% | AU$9.5m | n/a | PS20.1x | n/a | n/a | ||
AGH | AU$0.025 | -7.4% | -46.8% | AU$10.3m | n/a | PB0.7x | n/a | n/a | ||
MEM | AU$0.008 | 0% | -52.9% | AU$10.9m | n/a | PS14.9x | n/a | n/a | ||
RNO | AU$0.04 | -7.0% | -55.6% | AU$11.5m | n/a | PS1.4x | n/a | n/a | ||
NYR | AU$0.065 | -18.8% | -18.8% | AU$11.7m | n/a | PS4x | n/a | n/a | ||
ATX | AU$0.061 | 1.7% | -28.2% | AU$11.8m | n/a | PS6.3x | n/a | n/a | ||
FRE | AU$0.067 | 0% | -59.4% | AU$12.0m | n/a | PS6.6x | n/a | n/a |